K Number
K964609
Device Name
ACTALYKE ACTIVATED CLOTTING TIME TEST SYSTEM/CLOTTING TIME TUBES/WHOLE BLOOD QC KIT/ACTALYKE ELECTRONIC CLOTTING TUBE
Date Cleared
1997-03-06

(108 days)

Product Code
Regulation Number
864.7140
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The Actalyke Activated Clotting Time System and Test Tubes are intended for use in the measurement of the activated clotting time test (ACT). Current markets using the ACT include: bypass surgery, vascular surgery, transplant surgery, renal dialysis, ECMO, cardiac catheterization and Percutaneous Transluminal Coronary Angioplasty (PTCA), Critical Care, and other medical therapies requiring heparin anticoagulation.
Device Description
The Actalyke System is a portable, battery operated device designed to perform a range of whole blood coagulation tests at the patient's bedside using Activated Clotting Time (ACT) measurement techniques. Each test well of the Actalyke Instrument incorporates a highly sensitive clot detection mechanism. Operationally, the detection mechanism comprises a magnet located inside a test tube and two solid state magnetic detectors positioned within the test well - one situated at 0° and another situated at 90° with respect to the test tube. When a test tube is inserted into the test well, the detector at 0° senses the presence of the magnet as the tube slowly rotates. As clotting forms, the fibrin strands cause the magnet to rotate within the tube such that its presence is sensed by the detector at 90° (indicating the occurrence of clotting and triggering end-point detection). This two-point detection sensing system is an improvement in ACT detection methods and minimizes the possibility of a missed end-point. Each Actalyke test tube has a barcode label affixed to it, which is read by the Actalyke instrument to determine the test tube type (i.e., celite, kaolin, or glass bead), If the result is printed (optional), the normal range for the identified test tube type will be printed. The lot number and expiration date of each tube are also identified on the barcode label.
More Information

HEMOCHRON Whole Blood Coagulation System and Activated Clotting Time Tests (pre-1976)

Not Found

No
The device description details a mechanical and magnetic clot detection mechanism, and there is no mention of AI, ML, or related concepts in the summary.

No.
A therapeutic device is one that performs treatment, prevention, or cures a disease or condition. This device is used for diagnostic purposes by measuring activated clotting time (ACT).

Yes
The device is intended for use in the measurement of the activated clotting time test (ACT) for various medical therapies requiring heparin anticoagulation, and its description highlights its function in detecting clotting, which is a diagnostic measurement.

No

The device description clearly outlines a portable, battery-operated hardware instrument with physical components (magnet, magnetic detectors) designed to perform a physical measurement (clotting time). While it likely includes software for processing and display, it is fundamentally a hardware device.

Yes, this device is an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use explicitly states that the system is for "use in the measurement of the activated clotting time test (ACT)". This is a test performed on a biological sample (whole blood) to provide information about a patient's health status (their clotting time).
  • Device Description: The device performs a "range of whole blood coagulation tests". Whole blood is a biological specimen.
  • Performance Studies: The performance studies involve testing "Patient samples", which are biological specimens. The results are measurements of ACT in seconds, which are diagnostic parameters.
  • Predicate Device: The predicate device is the "HEMOCHRON Whole Blood Coagulation System and Activated Clotting Time Tests", which is also an IVD device used for similar diagnostic testing.

The device analyzes a biological sample (whole blood) in vitro (outside the body) to provide diagnostic information (activated clotting time). This aligns directly with the definition of an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

The Actalyke Activated Clotting Time System and Test Tubes are intended for use in the measurement of the activated clotting time test (ACT). Current markets using the ACT include: bypass surgery, vascular surgery, transplant surgery, renal dialysis, ECMO, cardiac catheterization and Percutaneous Transluminal Coronary Angioplasty (PTCA), Critical Care, and other medical therapies requiring heparin anticoagulation.

Product codes

Not Found

Device Description

Actalyke System

The Actalyke System is a portable, battery operated device designed to perform a range of whole blood coagulation tests at the patient's bedside using Activated Clotting Time (ACT) measurement techniques.

ACT Measurement Principles

A step-by-step description of the Actalyke ACT measurement principle is provided below:

  1. Each test well of the Actalyke Instrument incorporates a highly sensitive clot detection mechanism.
  2. Operationally, the detection mechanism comprises a magnet located inside a test tube and two solid state magnetic detectors positioned within the test well - one situated at 0° and another situated at 90° with respect to the test tube.
  3. When a test tube is inserted into the test well, the detector at 0° senses the presence of the magnet as the tube slowly rotates.
  4. As clotting forms, the fibrin strands cause the magnet to rotate within the tube such that its presence is sensed by the detector at 90° (indicating the occurrence of clotting and triggering end-point detection). This two-point detection sensing system is an improvement in ACT detection methods and minimizes the possibility of a missed end-point.

Actalyke Activated Clotting Time Tubes

Each Actalyke test tube has a barcode label affixed to it, which is read by the Actalyke instrument to determine the test tube type (i.e., celite, kaolin, or glass bead), If the result is printed (optional), the normal range for the identified test tube type will be printed. The lot number and expiration date of each tube are also identified on the barcode label.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

patient's bedside

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Normal Range Study:

  • Celite Normal Range Study: Tested 15 patient samples with both Hemochron and Actalyke instruments and tubes. Data includes individual patient results and statistical summaries (mean, std, %cv, max, min, x-2std, x+2std, x-3std, x+3std).
  • Kaolin Normal Range Study: Tested 15 patient samples with both Hemochron and Actalyke instruments and tubes. Data includes individual patient results and statistical summaries.
  • Glass Bead Normal Range Study: Tested 15 patient samples with both Hemochron and Actalyke instruments and tubes. Data includes individual patient results and statistical summaries.

Correlation with predicate device:

  • Celite tubes: Compared mean ACT data at different heparin concentrations (0, 1, 3, 5 u/ml heparin) for combinations of Hemochron and Actalyke instruments and tubes.
  • Kaolin tubes: Compared mean ACT data at different heparin concentrations (0, 1, 3, 5 u/ml heparin) for combinations of Hemochron and Actalyke instruments and tubes.
  • Glass Bead tubes: Compared mean ACT data at different heparin concentrations (0, 0.3, 0.6, 1, 2 u/ml heparin) for combinations of Hemochron and Actalyke instruments and tubes.

Key results:

  • Actalyke Instrument/Actalyke ACT tubes yielded similar normal ranges when compared to the Hemochron Instrument/Hemochron ACT tubes when utilizing the same normal patient samples.
  • Actalyke Instrument/Actalyke ACT tubes yielded high correlation with Hemochron Instrument/Hemochron ACT tubes when utilizing the same patient samples.
  • Hemochron Instruments/Actalyke ACT tubes yielded high correlation with Hemochron Instrument/Hemochron ACT tubes when utilizing the same patient samples.
  • Actalyke Instruments/Hemochron ACT tubes yielded high correlation with Hemochron Instrument/Hemochron ACT tubes when utilizing the same patient samples.

Key Metrics

Not Found

Predicate Device(s)

HEMOCHRON Whole Blood Coagulation System and Activated Clotting Time Tests (pre-1976)

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 864.7140 Activated whole blood clotting time tests.

(a)
Identification. An activated whole blood clotting time tests is a device, used to monitor heparin therapy for the treatment of venous thrombosis or pulmonary embolism by measuring the coagulation time of whole blood.(b)
Classification. Class II (performance standards).

0

K964609

    1. 510(k) Summary of Information Respecting Safety and Effectiveness
  • A. Legally Marketed Device

Array Medical claims substantial equivalence to the HEMOCHRON Whole Blood Coagulation System and Activated Clotting Time Tests (pre-1976), currently in commercial distribution by International Technidyne Corporation.

  • B. Device Description

Actalyke System

The Actalyke System is a portable, battery operated device designed to perform a range of whole blood coagulation tests at the patient's bedside using Activated Clotting Time (ACT) measurement techniques.

ACT Measurement Principles

A step-by-step description of the Actalyke ACT measurement principle is provided below:

  • l ) Each test well of the Actalyke Instrument incorporates a highly sensitive clot detection mechanism.
    1. Operationally, the detection mechanism comprises a magnet located inside a test tube and two solid state magnetic detectors positioned within the test well - one situated at 0° and another situated at 90° with respect to the test tube. See below:

Image /page/0/Figure/12 description: This image shows a diagram of a test well with a tube inside. There is a detector at 90 degrees and a detector at 0 degrees. A magnet is also present in the diagram, positioned near the tube.

    1. When a test tube is inserted into the test well, the detector at 0° senses the presence of the magnet as the tube slowly rotates.
    1. As clotting forms, the fibrin strands cause the magnet to rotate within the tube such that its presence is sensed by the detector at 90° (indicating the occurrence of clotting and triggering end-point detection). This two-point detection sensing system is an improvement in ACT detection methods and minimizes the possibility of a missed end-point.

1

Device Description (continued)

Actalyke Activated Clotting Time Tubes

Each Actalyke test tube has a barcode label affixed to it, which is read by the Actalyke instrument to determine the test tube type (i.e., celite, kaolin, or glass bead), If the result is printed (optional), the normal range for the identified test tube type will be printed. The lot number and expiration date of each tube are also identified on the barcode label.

Cat. No.Recomm. UseActivatorDescription
C-ACTBypass and
Vascular surgeryCelite (14 mg.)Glass tube with black
flip-top tube
and barcode label.
2.0 ml blood sample
K-ACTBypass surgery
in the presence
aprotininKaolin (14 mg.)Glass tube with gold
flip-top and barcode
label. 2.0 ml blood
sample
G-ACTRenal DialysisGlass beads (50 mg.)Plastic tube with clea
flip-top and barcode
label. 0.4 ml blood
sample

NOTE: Used Actalyke test tubes should be disposed of in accordance with each institution's policy regarding biohazardous materials.

C. Intended Use

The Actalyke Activated Clotting Time System and Test Tubes are intended for use in the measurement of the activated clotting time test (ACT). Current markets using the ACT include: bypass surgery, vascular surgery, transplant surgery, renal dialysis, ECMO, cardiac catheterization and Percutaneous Transluminal Coronary Angioplasty (PTCA), Critical Care, and other medical therapies requiring heparin anticoagulation.

2

D. Comparison with Predicate Device

(

Feature Comparison of Actalyke and HEMOCHRON Systems

ActalykeHEMOCHRON
Intended UseActivated Clotting Time TestActivated Clotting Time Test
Method of detectionMagnetic detectionMagnetic Detection
Reactive Ingredients (tubes)Celite, kaolin, glass-beadsCelite, kaolin, glass-beads
Storage of tubesRoom temperatureRoom temperature
Materials providedInstrument
Test Tubes
ControlsInstrument
Test Tubes
Controls
Instrument SpecificationsNo. Test Channels: 1 or 2 Timing Range: 0-1500 Operating Time on Battery (hours): 4-6 Test barcode identification Options: PrinterNo. Test Channels: 1 or 2 Timing Range: 0-1500 Operating Time on Battery (hours): 4-6
PerformanceC-ACT 105-130 sec.
K-ACT 114-130 sec.
G-ACT 165-212 sec.
Normal Range studiesCA510 105-167 sec.
K-ACT 91-151 sec.
P214 145-195 sec.
Normal Range studies

3

E. Performance Data

Specific Performance Characteristics

Normal Range Study

Celite Normal Range Study

InstrumentHemochronActalyke
TubesHemochronActalykeHemochronActalyke
NoPatient ID
1S011129133103117
2S012124126118125
3S013112118106113
4S014110110100109
5S015104112113125
6S016109114108117
7S002108117109112
8S017116119112123
9S018107114112117
10S019101108100110
11S020109115110116
12S021121129120130
13S022104106102112
14S023113124110122
15S024108112110115
mean111.67117.13108.87117.53
std7.837.835.956.20
%cv7.016.685.475.27
max129.00133.00120.00130.00
min101.00108.00100.00109.00
x-2std96.02101.4896.97105.14
x+2std127.32132.79120.77129.93
x-3std88.1993.6591.0198.94
x+3std135.14140.62126.72136.13

Kaolin Normal Range Study

(.

.. '-

InstrumentHemochronActalyke
TubesHemochronActalykeHemochronActalyke
NoPatient ID
1S033118128107117
2S034118119108118
3S035116120105119
4S036122128115125
5S037114122110119
6S004116125118128
711L001119130115122
8S005122132119128
9S037108118108121
10S038112121114120
11S009122133122127
12S030119127121126
13S031115121116122
14S039110125106118
15S040109119108119
mean116.00124.53112.80121.93
std4.664.965.713.88
%cv4.023.985.063.18
max122.00133.00122.00128.00
min108.00118.00105.00117.00
x-2std106.68114.62101.38114.17
x+2std125.32134.44124.22129.70
x-3std102.02109.6795.67110.29
x+3std129.98139.40129.93133.58

4

Glass Bead Normal Range Study

InstrumentHemochronActalyke
TubesHemochronActalykeHemochronActalyke
NoPatient ID
1S051188180188203
2S027175168163185
3S025177167177199
4S052178199199198
5S028166169178178
6S019162167163167
7S035168197158199
8S045173172179172
911L001171190155189
10S049191186157203
11S048174169181197
12S006169180185185
13S016157176166177
14S030150178167183
15S009145179170188
mean169.60178.47172.40188.20
std12.5510.5612.7611.45
%cv7.405.917.406.08
max191.00199.00199.00203.00
min145.00167.00155.00167.00
X-2std144.50157.36146.88165.31
x+2std194.70199.58197.92211.09
x-3std131.95145.80134.12153.86
x+3std207.25210.13210.68222.54

5

Correlation with predicate device

Summary Celite tubes
--------------------------
Mean datau/ml heparin
Instrumenttube0135
HemochronHemochron120.6252.4448.8782.2
HemochronActalyke123264431.8709.2
ActalykeHemochron114214.2377.4548
ActalykeActalyke122235.2386.8598.6

Image /page/5/Figure/3 description: This figure is a line graph titled "Mean total data Celite tubes". The x-axis is labeled "u/ml heparin" and ranges from 0 to 5. The y-axis is labeled "ACT (seconds)" and ranges from 0 to 1000. There are 4 lines on the graph, representing Hemochron and Actalyke.

6

Summary Kaolin tubes

(

Mean datau/ml heparin
instrumenttube0135
HemochronHemochron129.6291533.4848.75
HemochronActalyke137297.6511780.2
ActalykeHemochron124264.4497735.6

Image /page/6/Figure/2 description: The image is a graph titled "Mean total data Kaolin tubes". The x-axis is labeled "u/ml heparin" and ranges from 0 to 5. The y-axis is labeled "ACT (seconds)" and ranges from 0 to 900. There are four lines on the graph, representing Hemochron and Actalyke, showing the relationship between heparin concentration and ACT.

7

Summary Glass Bead tubes

Mean datau/ml heparin
Instrumenttube00.30.612
HemochronHemochron179.0294.4345.6451.0636.2
HemochronActalyke181.0270.2336.0402.0584.4
ActalykeHemochron178.4272.6337.6378.4554.6

Image /page/7/Figure/2 description: The image is a graph titled "Mean total data Glass bead tubes". The x-axis is labeled "u/ml heparin" and ranges from 0 to 2. The y-axis is labeled "ACT (seconds)" and ranges from 0.0 to 800.0. There are multiple lines on the graph, representing Hemochron and Actalyke.

DATA SUMMARY

  • Actalyke Instrument/Actalyke ACT tubes yielded similar normal ranges when compared . to the Hemochron Instrument/Hemochron ACT tubes when utilizing the same normal patient samples
  • Actalyke Instrument/Actalyke ACT tubes yielded high correlation with Hemochron . Instrument/Hemochron ACT tubes when utilizing the same patient samples
  • Hemochron Instruments/Actalyke ACT tubes yielded high correlation with . Hemochron Instrument/Hemochron ACT tubes when utilizing the same patient samples
  • Actalyke Instruments/Hemochron ACT tubes yielded high correlation with . Hemochron Instrument/Hemochron ACT tubes when utilizing the same patient samples

. . .

ë;